Microsoft rated a Strong Buy: 32% upside to $600 as AI boosts Azure growth. Valuation near lows; legal risk manageable. Read ...
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results